from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0664/vapB8

LFCtreatmentdescriptionclass of inhibitor

-0.828

Amikacinug/mL Amikacintranslation

-0.912

Cap5-10ug/mL Capreomycintranslation

-0.548

Rox10-50 ug/mL Roxithromycintranslation

0.076

SM2-5 ug/mL Streptomycintranslation

-0.256

Tet5-10 ug/mL Tetracyclinetranslation

-0.198

Rif0.2-5ug/mL Rifampicintranscription

-1.122

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.184

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.762

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.668

CPZ10-50 ug/mL Chlorpromazinerespiration

0.500

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.168

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.629

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.075

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.832

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.442

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.651

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.796

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.068

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.748

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.406

KCN5-20 ug/mL Potassium cyaniderespiration

-0.398

NaN30.2-2 mM Sodium aziderespiration

-0.234

Nigericin50 uM Nigericinrespiration

0.303

TRC10-150 ug/mL Triclosanrespiration

-0.017

TRZ10-25 ug/mL Thioridazinerespiration

0.496

Valinomycin0.5-10 uM Valinomycinrespiration

-0.651

ZnSO42 mM ZnSO4respiration

3.296

menadione6-10 ug/mL Menadionerespiration

-0.084

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.279

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.097

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.283

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.546

NRP_1Non-replicating persistence stage 1dosRassociated

-0.050

Amp0.2mg/mL AmpicillincellWall

0.025

Cephalexin20-100 ug/mL CephalexincellWall

-0.197

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.106

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.160

EMB10-20 ug/mL EthambutolcellWall

0.444

Eta12-40 ug/mL EthionamidecellWall

0.737

INH0.2-0.4 ug/mL IsoniazidcellWall

0.198

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.210

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.182

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.264

BZA0.12 mg/mL BenzamidearomaticAmides

0.452

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.670

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.550

H2O24 mM hydrogen peroxideDNAdamaging

-0.446

Levo10 ug/mL LevofloxacinDNAdamaging

-0.192

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.090

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.209

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.030

UVUV-irradiationDNAdamaging

1.384

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.036

Antimycin12.5-50 ug/mL Antimycin A?

0.136

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.021

PA_110-50 ug/mL Antitubercular compound PA-1?

0.011

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.387

PA8240.2-2 ug/mL PA-824?

0.059

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.060

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.013

Verapamil50 uM Verapamil?

0.187

mercaptoethanol2 mM 2-Mercaptoethanol?

0.023

methoxatin10-20 ug/mL Methoxatin?